Cns & Neurological Disorders-drug Targets

Aims & Scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders e.g. disease specific proteins, receptors, enzymes, genes.

CNS & Neurological Disorders - Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts for publication original research articles, letters, reviews and drug clinical trial studies.

As the discovery, identification, characterization and validation of novel human drug targets for neurological and CNS drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

《Cns & Neurological Disorders-drug Targets》是一本由Bentham Science Publishers B.V.出版商出版的专业医学期刊，该刊创刊于2006年，刊期Bimonthly，该刊已被国际权威数据库SCIE收录。在中科院最新升级版分区表中，该刊分区信息为大类学科：医学4区，小类学科：神经科学 4区；药学 4区；在JCR（Journal Citation Reports）分区等级为Q2。该刊发文范围涵盖NEUROSCIENCES等领域，旨在及时、准确、全面地报道国内外NEUROSCIENCES工作者在该领域取得的最新研究成果、工作进展及学术动态、技术革新等，促进学术交流，鼓励学术创新。2023年影响因子为2.7，平均审稿速度 较慢,6-12周 。